|

Metarrestin Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Malignant Peripheral Nerve Sheath Tumor1
  • Metastatic Pancreatic Cancer1
  • Advanced Breast Cancer1
  • Pediatric Solid Tumor1
  • Colorectal Neoplasms1

Fairway, Kansas1 trial

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

University of Kansas

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.